Published by 1000Startups.com. Reading time: about seven minutes. Cost of acting on it: ten phone calls.

The reason field in your CRM says “price.” The reason in your CRM is almost never price. It is simply the kindest thing one human being can say to another human being’s face after deciding not to buy from them. What follows is the honest version, the research behind it, and the ten phone calls that will tell you more about your positioning than any strategy offsite ever has.

Q: Everyone says we lost on price. Why should I doubt my own sales data?

Because you are not looking at what happened. You are looking at a record of what a polite person told your rep. Those are two different datasets, and the gap between them has been measured.

In an analysis of 10,247 buyer conversations, User Intuition found that 62.3% of buyers named price as a reason at first, while only 18.1% were actually driven by price. Primary Intelligence, drawing on more than 50,000 buyer interviews, found sales reps attribute losses to price 48% of the time, while buyers name it as the true primary factor 23% of the time. In non-commodity categories, price is the deciding factor less than 15% of the time. (Both figures compiled by Elevated Signal, “Win/Loss Analysis: Methodology and ROI,” 2026: elevatedsignal.com/insights/win-loss-analysis)

Put plainly: price is the polite answer. It is not usually the true one.

Warren Buffett has spent sixty years drawing the distinction that your CRM keeps collapsing. “Price is what you pay. Value is what you get,” he told Berkshire Hathaway shareholders in his 2008 letter, and the sentence works just as well pointed at your own pipeline. A buyer who says you were too expensive is usually telling you that the value never became legible to them. That is a positioning problem wearing a pricing costume, and a discount will not fix it.

Q: Can you show me that gap in a picture?

Happily. This is the entire problem in one chart, and it is worth pinning above the desk of whoever owns your pipeline.

Sources: User Intuition (10,247 buyer conversations) and Primary Intelligence (50,000+ interviews), compiled by Elevated Signal, 2026. Clozd separately finds buyer and seller explanations for a lost deal agree only about 15% of the time.

Q: How unreliable is closed-lost data, exactly?

Unreliable enough that most companies are steering by it anyway. Clozd, which runs win-loss programs for a living, reports that buyer and seller reasons for lost deals align only about 15% of the time, meaning roughly 85% of CRM loss data is inaccurate or incomplete (clozd.com/guides/win-loss-analysis). In a study of 1,000 closed-lost opportunities, Clozd found the competitor tagged in the CRM was wrong in roughly 70% of deals, and separate research cited by the same firm puts reps wrong about why they win and lose around 60% of the time or worse. Salesforce research across 24 companies found half of CRM data inaccurate generally.

None of this means your reps are dishonest. It means they were standing in the wrong room. The decision was made in a meeting they were never invited to.

Q: Why would a stranger get a more honest answer than my own rep?

Because the buyer has no relationship to protect and nothing to soften. Nobody enjoys telling a real person that their demo was confusing, their pricing felt evasive, or that the other vendor simply seemed more competent. “We went with someone cheaper” ends the conversation kindly and lets everyone keep their dignity.

Clozd calls this politeness bias, and the examples are unpleasantly familiar: a buyer will not criticize the interface to the product manager who built it, and will not describe an aggressive rep to that rep’s VP of Sales. This is the same reason exit interviews are run by HR rather than by the departing employee’s manager, and it is why the findings are always more useful and more uncomfortable. Clozd reports that companies using a third party are more than twice as likely to be satisfied with the quality and depth of the feedback they get.

Buffett built a governance rule out of the same instinct. In Berkshire Hathaway’s Owner’s Manual he commits to reporting the pluses and the minuses, on the theory that “the CEO who misleads others in public may eventually mislead himself in private” (berkshirehathaway.com/owners.html). A closed-lost field stuffed with comfortable answers is that exact machinery, running quietly, one deal at a time, until the entire company sincerely believes a story no buyer ever told.

Q: If we did not lose on price and did not lose to a competitor, what did we lose to?

Very often, to the buyer’s own inability to get a decision made.

Matthew Dixon and Ted McKenna analyzed more than 2.5 million recorded sales conversations for The JOLT Effect and found that 40% to 60% of qualified deals end in no decision rather than in a competitive defeat. Of those, 44% were losses to the status quo, and 56% were buyers who genuinely wanted to move forward and froze anyway, out of fear of making the wrong call (jolteffect.com).

Gartner’s buyer research explains the mechanism: 77% of B2B buyers describe their most recent purchase as very complex or difficult, with buying groups of roughly six to ten stakeholders, each arriving with four or five independently gathered pieces of information (gartner.com/en/sales/insights/b2b-buying-journey). A large share of your losses are not defeats. They are people who could not build consensus and quietly stopped answering email.

One useful corollary from the same JOLT research: piling on urgency and fear of missing out backfires the overwhelming majority of the time. The buyer’s dominant fear is not missing out. It is messing up.

Q: Which deals do I call? Can I start with the interesting ones?

No, and this is where most attempts quietly fail. The deals you remember are the ones with a story attached, and the ones with a story attached are by definition unrepresentative. Selection bias will hand you a confident, well-argued, completely wrong conclusion.

Take the last ten consecutive losses. No exceptions, no substitutions, including the embarrassing ones and especially the boring ones.

Q: What do I actually ask?

Four questions, twenty minutes, no rebuttal:

• When did you first think we might not be the answer?
• What did you need that you could not find?
• Who else was in the room?
• What would have changed your mind?

Then stop talking. The silence after question four is where the useful material lives.

Q: What is the fastest way to ruin one of these calls?

Defending yourself. One correction, one “well, actually we do have that feature,” and you have converted a research interview into a sales call, at which point the buyer reverts to being polite and you learn nothing. The urge to defend is what destroys the data.

A close second: sending the rep who lost the deal. They cannot help but negotiate, and the buyer cannot help but be gentle with them.

Q: Should I interview the deals we won, too?

Yes, as a control group. Losses tell you what repels people. Wins tell you what actually persuaded them, which is reliably something nobody in your marketing department has ever written down. Roughly three wins for every ten losses is enough to keep you honest.

Q: How do I keep one dramatic story from hijacking the strategy meeting?

Count before you quote. One vivid interview will run away with the room, get repeated in the next board deck, and reshape a roadmap all by itself. Ten interviews, coded into categories and tallied, will calmly reveal that the vivid one was an outlier of exactly one.

Tally first. Then, and only then, pull the quotes that illustrate the pattern you actually found.

Q: Is there an existing model for reviewing failure without destroying people?

Medicine has run one for over a century. The morbidity and mortality conference traces back to Ernest Amory Codman at Massachusetts General Hospital in the early 1900s, whose “end result system” tracked every patient to the final outcome and reviewed the bad ones openly. His colleagues were not charmed; he was vilified and left the hospital staff. His method nonetheless shaped the American College of Surgeons hospital standards of 1916, and in 1983 the Accreditation Council for Graduate Medical Education made a weekly review of complications and deaths a requirement for residency accreditation (see the AMA Journal of Ethics, “Error in Medicine: The Role of the Morbidity and Mortality Conference,” and the ACGME requirement documented in the surgical literature).

The modern version is deliberately non-punitive and systems-focused: the goal is to find the cause without destroying the clinician. Medicine got measurably safer because that meeting is scheduled, structured, and mandatory. Your pipeline deserves the same institution, and it costs you an hour a month.

Q: What does a lost deal reason actually translate to?

Keep this table next to the CRM export. It is not a substitute for the interview, but it will tell you what to listen for.

What the CRM says	What it often actually means	What to ask in the interview
Price / too expensive	Value was never made legible, or the buyer could not defend the spend internally	Who would have had to approve this, and what would they have needed to see?
Went with a competitor	The competitor felt like the safer career decision, not the better product	What made the other option feel less risky than us?
Bad timing	Nobody could get the decision made, so the process quietly stopped	Where exactly did this stall, and who stopped replying first?
No budget	The problem was real but never got ranked against other priorities	What did the money go to instead, and why did that win?
Missing feature	One skeptic in the buying group used a feature gap to justify a no	Who raised that, and was it the reason or the excuse?

Q: How often should we run this, and does it actually move the number?

Ten interviews a quarter, twenty minutes each, reviewed in one blameless hour. That is the whole program.

As for the payoff: Gartner research cited by Clozd suggests companies that invest in rigorous win-loss analysis may see improvements in win rate as high as 50%. Treat any single headline number as directional rather than promised. The more reliable argument is the competitive one. Pragmatic Marketing has found that fewer than 20% of companies conduct formal post-decision interviews at all, which means the honest version of your own loss data is still, remarkably, an edge.

Q: I am a consultant. Can I sell this?

It is one of the cleanest offers in professional services. A defined win-loss study sits neatly between a fixed-fee audit and a full engagement, it prices naturally per interview, and it delivers something the client physically cannot obtain on their own, because the client is the exact reason nobody will answer honestly. You are not selling analysis. You are selling the fact that you are not them.

Q: What is the bottom line?

The most valuable document in your company is the one nobody has written: an honest, counted list of the reasons people did not buy. It costs ten phone calls and roughly four hours. It is the fastest positioning diagnostic in existence. And the only thing standing between you and it is that nobody enjoys making the calls.

Buffett named the failure mode precisely in his 2024 letter to shareholders, writing that a decent batting average is all anyone can hope for and that “the cardinal sin is delaying the correction of mistakes” – what Charlie Munger called thumb-sucking. Problems, Munger liked to remind him, cannot be wished away. They require action, however uncomfortable that action happens to be. Ten phone calls is a remarkably cheap form of uncomfortable action.

Make the calls. Bring a tally sheet. Do not defend anything.

Sources

• Elevated Signal, “Win/Loss Analysis: Methodology and ROI” (2026), compiling User Intuition and Primary Intelligence data: elevatedsignal.com/insights/win-loss-analysis
• Clozd, “What is Win-Loss Analysis?” and related research on CRM accuracy and politeness bias: clozd.com/guides/win-loss-analysis
• Matthew Dixon and Ted McKenna, The JOLT Effect (2022), based on 2.5 million recorded sales conversations: jolteffect.com
• Gartner, “The B2B Buying Journey”: gartner.com/en/sales/insights/b2b-buying-journey
• AMA Journal of Ethics, “Error in Medicine: The Role of the Morbidity and Mortality Conference” (2005), and ACGME weekly review requirements (1983) documented in the surgical education literature
• Pragmatic Marketing, on the share of companies conducting formal post-decision interviews
• Warren E. Buffett, Berkshire Hathaway shareholder letters (2008 and 2024) and An Owner’s Manual: berkshirehathaway.com/owners.html

Published by 1000Startups.com, a practical resource for founders, operators, and consultants building companies from the first customer forward.